Loading
Latest filing published 15 Mar 2016 for ImmunoCellular Therapeutics, Ltd..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Anthony Gringeri appears in our data through filings on ImmunoCellular Therapeutics, Ltd. shares, published by SEC (Form 4). In total, 5 filings cover trades dated from 23 December 2013 to 11 March 2016.
The open-market record is one-sided, with 3 purchases worth €23k and not one sale. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants.
Most recently, on 15 March 2016, the filings show a share grant in ImmunoCellular Therapeutics, Ltd. The most recent open-market purchase was published on 20 February 2015, 4,264 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations